Sonelokimab | Interleukin Related interleukin-related.com

Product Name :
Sonelokimab

Search keywords :
Sonelokimab

drugId :
null

Target Vo:
Interleukin-17F

Target Vo Short Name :
IL-17F

Moa_Name:
Interleukin-17F inhibitors

First Approval Country :

First Approval Date Filter:
null

Origin Company_Name :
Ablynx Nv

Active Company_Name :
Bond Avillion 2 Development Lp

Active Indication_Name:
Hidradenitis Suppurativa

In Active Indication_Name:

Termination Status :

China Termination Status :

Highest Status:
Phase 3 Clinical

China Highest Status:

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
Cy5-conjugated AffiniPure Goat Anti-Mouse IgG H&L
EGFR Antibody
Calnexin Antibody: Calnexin Antibody is a non-conjugated and Rabbit origined polyclonal antibody about 68 kDa, targeting to Calnexin. It can be used for WB,IHC-F,IHC-P,ICC/IF,ELISA assays with tag free, in the background of Human, Mouse, Rat.

Author: Interleukin Related

Related Posts